マグネビスト（SH L 451A）の磁気共鳴血管造影における個体内用量比較試験

基本情報

NCT ID

NCT00652418

ステータス

完了

試験のフェーズ

第2相

試験タイプ

介入

目標被験者数

12

治験依頼者名

Bayer

概要

The objective of the study was to compare the efficacy of Magnevist (SH L 451 A) at doses of 0.1 mmol/kg and 0.2 mmol/kg in contrast-enhanced 3D-Magnetic Resonance Angiography in three regions (abdominal, femoral, and leg regions) for visualization of arteries, evaluating 179 not assessable: caused by contrast media in the evaluation of structural abnormalities. Magnevist (SH L 451 A) was administered intravenously in a crossover design in patients with arterial disease in the abdominal to leg regions. The safety of the 0.2 mmol/kg dose was also assessed.

対象疾患

介入

依頼者（Sponsor）